Striatal dopamine D2/D3 receptor regulation of human reward processing and behaviour

被引:0
|
作者
Osugo, Martin [1 ,2 ,3 ]
Wall, Matthew B. [4 ,5 ]
Selvaggi, Pierluigi [6 ,7 ]
Zahid, Uzma [1 ,8 ]
Finelli, Valeria [1 ]
Chapman, George E. [1 ,2 ,9 ,10 ]
Whitehurst, Thomas [2 ,11 ]
Onwordi, Ellis Chika [1 ,2 ,11 ,12 ]
Statton, Ben [2 ,5 ]
Mccutcheon, Robert A. [1 ,2 ,13 ,14 ]
Murray, Robin M. [1 ]
Marques, Tiago Reis [1 ,2 ]
Mehta, Mitul A. [6 ]
Howes, Oliver D. [1 ,2 ,3 ]
机构
[1] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England
[2] Imperial Coll London, MRC Lab Med Sci, London, England
[3] South London & Maudsley NHS Fdn Trust, London, England
[4] Perceptive, London, England
[5] Imperial Coll London, Fac Med, London, England
[6] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Neuroimaging, London, England
[7] Univ Bari Aldo Moro, Dept Translat Biomed & Neurosci, Bari, Italy
[8] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England
[9] UCL, Fac Brain Sci, Div Psychiat, London, England
[10] North London NHS Fdn Trust, London, England
[11] East London NHS Fdn Trust, London, England
[12] Queen Mary Univ London, Wolfson Inst Populat Hlth, Ctr Psychiat & Mental Hlth, London, England
[13] Univ Oxford, Dept Psychiat, Oxford, England
[14] Oxford Hlth NHS Fdn Trust, Oxford, England
基金
欧盟地平线“2020”; 英国医学研究理事会; 英国惠康基金;
关键词
NEGATIVE SYMPTOM SCALE; SCHIZOPHRENIA; ARIPIPRAZOLE; ANTICIPATION; ACTIVATION; PREDICTION; BIFEPRUNOX; MOTIVATION; GLUTAMATE; OUTCOMES;
D O I
10.1038/s41467-025-56663-7
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Signalling at dopamine D2/D3 receptors is thought to underlie motivated behaviour, pleasure experiences and emotional expression based on animal studies, but it is unclear if this is the case in humans or how this relates to neural processing of reward stimuli. Using a randomised, double-blind, placebo-controlled, crossover neuroimaging study, we show in healthy humans that sustained dopamine D2/D3 receptor antagonism for 7 days results in negative symptoms (impairments in motivated behaviour, hedonic experience, verbal and emotional expression) and that this is related to blunted striatal response to reward stimuli. In contrast, 7 days of partial D2/D3 agonism does not disrupt reward signalling, motivated behaviour or hedonic experience. Both D2/D3 antagonism and partial agonism induce motor impairments, which are not related to striatal reward response. These findings identify a central role for D2/D3 signalling and reward processing in the mechanism underlying motivated behaviour and emotional responses in humans, with implications for understanding neuropsychiatric disorders such as schizophrenia and Parkinson's disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Amphetamine decreases behavioral inhibition by stimulation of dopamine D2, but not D3, receptors
    van Gaalen, Marcel M.
    Unger, Liliane
    Jongen-Relo, Ana-Lucia
    Schoemaker, Hans
    Gross, Gerhard
    BEHAVIOURAL PHARMACOLOGY, 2009, 20 (5-6): : 484 - 491
  • [42] Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor
    Blasiak, Ewa
    Lukasiewicz, Sylwia
    Szafran-Pilch, Kinga
    Dziedzicka-Wasylewska, Marta
    PHARMACOLOGICAL REPORTS, 2017, 69 (02) : 235 - 241
  • [43] The Dopamine Stabilizer (-)-OSU6162 Occupies a Subpopulation of Striatal Dopamine D2/D3 Receptors: An [11C] Raclopride PET Study in Healthy Human Subjects
    Tolboom, Nelleke
    Berendse, Henk W.
    Leysen, Josee E.
    Yaqub, Maqsood
    van Berckel, Bart N. M.
    Schuit, Robert C.
    Ponsen, Mirthe M.
    Bakker, Esther
    Hoetjes, Nikie J.
    Windhorst, Albert D.
    Carlsson, Maria L.
    Lammertsma, Adriaan A.
    Carlsson, Arvid
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (02) : 472 - 479
  • [44] Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation
    Etievant, Adeline
    Betry, Cecile
    Arnt, Jorn
    Haddjeri, Nasser
    NEUROSCIENCE LETTERS, 2009, 460 (01) : 82 - 86
  • [45] Novel Bivalent Ligands for D2/D3 Dopamine Receptors: Significant Cooperative Gain in D2 Affinity and Potency
    Gogoi, Sanjib
    Biswas, Swati
    Modi, Gyan
    Antonio, Tamara
    Reith, Maarten E. A.
    Dutta, Aloke K.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (12): : 991 - 996
  • [46] Acute administration of a dopamine D2/D3 receptor agonist alters behavioral and neural parameters in adult zebrafish
    Nabinger, D'bora Dreher
    Altenhofen, Stefani
    Buatois, Alexis
    Facciol, Amanda
    Peixoto, Julia Vasconcellos
    da Silva, Julia Maria Kuhl
    Chatterjee, Diptendu
    Rubensam, Gabriel
    Gerlai, Robert
    Bonan, Carla Denise
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2023, 125
  • [47] The dopamine D3-preferring D2/D3 dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia
    Watson, David J. G.
    King, Madeleine V.
    Gyertyan, Istvan
    Kiss, Bela
    Adham, Nika
    Fone, Kevin C. F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (02) : 208 - 224
  • [48] Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia
    Ohara, K
    Nakamura, Y
    Xie, DW
    Ishigaki, T
    Deng, ZL
    Tani, K
    Zhang, HY
    Kondo, N
    Liu, JC
    Miyasato, K
    Ohara, K
    BIOLOGICAL PSYCHIATRY, 1996, 40 (12) : 1209 - 1217
  • [49] Dopamine and glutamate dysfunctions in schizophrenia: Role of the dopamine D3 receptor
    Ludovic Leriche
    Jorge Diaz
    Pierre Sokoloff
    Neurotoxicity Research, 2004, 6 : 63 - 71
  • [50] Link between dopamine D1 and D2 receptors in rat and human striatal tissues
    Seeman, P
    Tallerico, T
    SYNAPSE, 2003, 47 (04) : 250 - 254